Acquired hemolytic anemia, unspecified
ICD-10 D59.9 is a billable code used to indicate a diagnosis of acquired hemolytic anemia, unspecified.
Acquired hemolytic anemia is a condition characterized by the premature destruction of red blood cells (RBCs), leading to a decrease in their lifespan and resulting in anemia. This condition can arise from various factors, including autoimmune disorders, infections, certain medications, and exposure to toxins. Unlike hereditary forms of hemolytic anemia, acquired hemolytic anemia is not genetically inherited but develops due to external factors. The clinical presentation may include fatigue, pallor, jaundice, dark urine, and splenomegaly. Diagnosis typically involves laboratory tests such as a complete blood count (CBC), reticulocyte count, and direct Coombs test to identify the underlying cause. Treatment strategies depend on the etiology and may include corticosteroids, immunosuppressive therapy, or addressing the underlying condition. The unspecified nature of this code indicates that the specific cause of hemolysis has not been determined, necessitating further investigation to guide appropriate management.
Detailed lab results, patient history, and treatment plans must be documented.
Patients presenting with fatigue, jaundice, and abnormal lab results indicating hemolysis.
Ensure that the cause of hemolysis is clearly documented to avoid misclassification.
Comprehensive patient history and physical examination findings are essential.
Patients with unexplained anemia and signs of hemolysis.
Consideration of differential diagnoses and appropriate lab tests to confirm the diagnosis.
Used to evaluate anemia and hemolysis.
Document the reason for the CBC and any relevant clinical findings.
Hematologists may require additional tests based on initial findings.
Common causes include autoimmune disorders, infections, certain medications, and exposure to toxins. Each cause may require different management strategies.
